Skip to main content
Singapore Clinical Research Institute will NEVER ask you to transfer money or disclose bank details over a call.

If in doubt, call the 24/7 ScamShield helpline at 1799, or visit the ScamShield website at www.scamshield.gov.sg (opens in new tab).

Singapore Clinical Research Institute (SCRI)

Dr Dharmaraj Karthikesan

Meet Dr Dharmaraj Karthikesan, a Malaysian interventional cardiologist specialising in complex coronary procedures and clinical trials, with training from Oxford and Thailand.

Last updated on 25 May 2026
A smiling man with dark hair wearing a navy blue suit and blue striped tie against a white background.

Dr Dharmaraj Karthikesan

Dr Dharmaraj Karthikesan is a consultant interventional cardiologist at Hospital Sultanah Bahiyah, Alor Setar, Malaysia. He specialises in complex coronary intervention and is keenly interested in conducting streamlined randomised clinical trials. He completed his interventional cardiology training in Malaysia and underwent a year of training at the Central Chest Institute of Thailand. He has also obtained an MSc in Clinical trials at the University of Oxford with a prestigious European Society of Cardiology (ESC) grant.

Dr Dharmaraj is a member of many leading national and international professional committees, including the National Heart Association of Malaysia (NHAM), European Society of Cardiology (ESC) and the Royal College of Physicians of Edinburgh. He actively participates in clinical trials and has authored several publications in reputed journals. He has delivered numerous lectures and presentations at both national and international conferences and seminars. He has won awards in both national and international meetings, including the American Society of Cardiology Conference, TCTAP cardiovascular summit and the Endovascular Cardiac Complication Conference.

Dr Dharmaraj's research focuses on complex coronary intervention and to improve current techniques and practices. His aim lies in conducting streamlined trials embedded into routine clinical care, allowing recruitment of patients without additional burden to busy clinicians. He is currently designing a clinical trial to address gaps in evidence within the complex coronary space.